Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Nicole C. Ammerman"'
Autor:
Saskia E. Mudde, Jodie A. Schildkraut, Nicole C. Ammerman, Corné P. de Vogel, Jurriaan E.M. de Steenwinkel, Jakko van Ingen, Hannelore I. Bax
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 31, Iss , Pp 345-352 (2022)
ABSTRACT: Objectives: Mycobacterium abscessus is an opportunistic respiratory pathogen in patients with underlying lung disease. It is infamously known for its low treatment success rates because of its resistance to multiple classes of antibiotics.
Externí odkaz:
https://doaj.org/article/64f40b3ee8c649f5b13b24f9e90cc139
Autor:
Steven Dunne, Andrew R. Willmer, Rosemary Swanson, Deepak Almeida, Nicole C. Ammerman, Kathleen A. Stringer, Edmund V. Capparelli, Gus R. Rosania
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 15 (2021)
Clofazimine (CFZ) is a poorly soluble, weakly basic, small molecule antibiotic clinically used to treat leprosy and is now in clinical trials as a treatment for multidrug resistant tuberculosis and COVID-19. CFZ exhibits complex, context-dependent ph
Externí odkaz:
https://doaj.org/article/04a8bb12f7d24456b7b5804dc83f18c1
Autor:
Andrew R. Willmer, Steven Dunne, Rosemary Swanson, Deepak Almeida, Nicole C. Ammerman, Kathleen A. Stringer, Edmund V. Capparelli, Gus R. Rosania
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 17 (2021)
Clofazimine (CFZ) is a weakly basic, small-molecule antibiotic used for the treatment of mycobacterial infections including leprosy and multidrug-resistant tuberculosis. Upon prolonged oral administration, CFZ precipitates and accumulates within macr
Externí odkaz:
https://doaj.org/article/8060cdf7bee147079522fc6df529c075
Autor:
Nicole C. Ammerman, Katherine I. Swanson, Jennifer M. Anderson, Timothy R. Schwartz, Eric C. Seaberg, Gregory E. Glass, Douglas E. Norris
Publikováno v:
Emerging Infectious Diseases, Vol 10, Iss 8, Pp 1478-1481 (2004)
Three-hundred ninety-two adult Dermacentor variabilis were collected from six Maryland counties during the spring, summer, and fall of 2002. Infection prevalence for spotted fever group Rickettsia was 3.8%, as determined by polymerase chain reaction.
Externí odkaz:
https://doaj.org/article/ce8d858c77fa4eb2a12c07a48c696021
Autor:
Yong S. Chang, Si-Yang Li, Henry Pertinez, Fabrice Betoudji, Jin Lee, Steven P. Rannard, Andrew Owen, Eric L. Nuermberger, Nicole C. Ammerman
Administration of tuberculosis preventive therapy (TPT) to individuals with latent tuberculosis infection is an important facet of global tuberculosis control. The use of long-acting injectable (LAI) drug formulations may simplify and shorten regimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69de10b5c1bec731cd951f498955f5ff
https://doi.org/10.1101/2023.04.12.536604
https://doi.org/10.1101/2023.04.12.536604
Autor:
Paul J Converse, Deepak V Almeida, Rokeya Tasneen, Vikram Saini, Sandeep Tyagi, Nicole C Ammerman, Si-Yang Li, Nicole M Anders, Michelle A Rudek, Jacques H Grosset, Eric L Nuermberger
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 8, p e0006728 (2018)
TRIAL REGISTRATION:ClinicalTrials.gov NCT03474198, NCT01659437.
Externí odkaz:
https://doaj.org/article/65826f0602744e5eba53c6c5af40e358
Autor:
Eric L. Nuermberger, Amit Kaushik, Jin Lee, Kelly E. Dooley, Olumide Martins, Nicole C. Ammerman
Publikováno v:
Antimicrobial Agents and Chemotherapy, 65(12):e01545-21. American Society for Microbiology
Antimicrob Agents Chemother
Antimicrob Agents Chemother
Mycobacterium abscessus lung disease is difficult to treat due to intrinsic drug resistance and the persistence of drug-tolerant bacteria. Currently, the standard of care is a multidrug regimen with at least 3 active drugs, preferably including a β-
Autor:
Jacqueline P Ernest, Timothy R. Sterling, Rada M. Savic, Nan Zhang, Robert Belknap, Kendra K. Radtke, Nicole C. Ammerman, Rosanna Boyd, Eric L. Nuermberger
Publikováno v:
Antimicrobial agents and chemotherapy, vol 65, iss 12
Antimicrobial Agents and Chemotherapy, 65(12):e01705-21. American Society for Microbiology
Antimicrob Agents Chemother
Antimicrobial Agents and Chemotherapy, 65(12):e01705-21. American Society for Microbiology
Antimicrob Agents Chemother
Rifapentine has facilitated treatment shortening for latent tuberculosis infection (LTBI) in combination with isoniazid once weekly for 3 months (3HP) or daily for 1 month (1HP). Our objective was to determine the optimal rifapentine dose for a 6-wee
Autor:
Kelly E. Dooley, Amit Kaushik, Jin Lee, Olumide Martins, Eric L. Nuermberger, Nicole C. Ammerman
Mycobacterium abscessus lung disease is difficult to treat due to intrinsic drug resistance and the persistence of drug-tolerant bacteria. Currently, the standard of care is a multi-drug regimen with at least 3 active drugs, preferably including a β
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::884557b3dec3780c0c8acdab87de88b5
https://doi.org/10.1101/2021.08.06.455495
https://doi.org/10.1101/2021.08.06.455495
Publikováno v:
Antimicrob Agents Chemother
Current treatment options for lung disease caused by Mycobacterium abscessus complex infections have limited effectiveness. To maximize the use of existing antibacterials and to help inform regimen design for treatment, we assessed the in vitro bacte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9cb1922aa37b4f968603ea88d498e5
https://europepmc.org/articles/PMC7848999/
https://europepmc.org/articles/PMC7848999/